Oric Pharmaceuticals

0 followers

‌

ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline target... Read more

Org chart

Jacob Chacko

Collapse
Matt Panuwat
Chief Business Officer
Dominic Piscitelli
Chief Financial Officer
Lori Friedman
Chief Scientific Officer
Pratik Multani
Chief Medical Officer
Christian V. Kuhlen
General Counsel
Edna Chow Maneval
Senior Vice President, Clinical Development
Dan Iazzetti
Vice President, Head Of People
Carmen Breslin
Executive Director

Board & advisors

Mardi C. Dier
Board Member
Richard Heyman
Founder & Chairman Scientific Advisory Board
Lori Kunkel
Board Member
Angie You
Board Member
Steve L. Hoerter
Board Member